NGR015

· AGC Biologics S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGR015, covering 2019-09-17 to 2019-09-17. Get the full timeline:

Most recent: Clinical Trial Update: NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed [Phase 3]

See pricing